NOTE 10 – WARRANTS

The Company has the following outstanding Warrants as of June 30, 2026, all of which are exercisable:

SCHEDULE OF OUTSTANDING WARRANTS

During the six months ended June 30, 2026, the Company issued immediately exercisable Warrants to purchase 225,000 shares of its common stock in connection with a Convertible Note financing (see Note 8 & 9). The Warrants are exercisable at $1.75 per share and expire between March and June 2031.

The Company determined the fair value of the Warrants at the grant date to be approximately $268,000 using the Black-Scholes option pricing model. The net proceeds from the financing were allocated between the Convertible Note and the Warrants on a relative fair value basis. As a result, approximately $234,000 of the net proceeds was allocated to the Warrants and recorded as a debt discount. This amount was recorded as additional paid-in capital, with a corresponding debt discount, which is being amortized to interest expense over the term of the applicable Convertible Note using the effective interest method.